MicroVision, Inc.

As of June 30, 2026, MicroVision, Inc. carries a market capitalization of 80.08M, placing it among publicly traded companies globally. Its enterprise value stands at 96.05M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

MicroVision, Inc.'s next confirmed earnings release is scheduled for October 28, 2026.

As of June 30, 2026, MicroVision, Inc. has 18.16M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 317.84, and the price-to-book ratio stands at 4.44.

These figures are as of June 30, 2026. The EV/Sales ratio of 38.21 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 96.05M versus a market cap of 80.08M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, MicroVision, Inc. maintains a current ratio of 0.68, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 220.43, indicating elevated leverage, while an interest coverage ratio of -8.01 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, MicroVision, Inc. posted a negative return on equity (ROE) of -233.74, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -99.65, reflecting losses generated across the asset base. The company generates approximately 13,318.47 in revenue per employee across its workforce of 188.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.82 indicates how many times MicroVision, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, MicroVision, Inc. recorded 98,908.90 in income tax expense. The company reported a pretax loss of -99.87M and -99.97M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on July 31, 2026, MicroVision, Inc.'s stock has declined approximately 76.72% over the past 52 weeks. The 50-day moving average sits at 0.33, while the 200-day moving average is 0.62.

Over the twelve months ended June 30, 2026, MicroVision, Inc. generated 2.51M in revenue and converted that into -99.97M in net income, yielding earnings per share of -0.55. EBITDA reached -81.95M, while operating income came in at -77.51M.

As of June 30, 2026, MicroVision, Inc. holds 23.82M in cash and equivalents against 39.78M in total debt, resulting in a net debt position of -2.32M. Total book value stands at 18.05M, with working capital of -14.13M providing operational flexibility.

MicroVision, Inc. produced -59.07M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -717,746.00 in capital expenditures, free cash flow totaled -59.78M - equivalent to -0.33 per share.

Over the twelve months ended June 30, 2026, MicroVision, Inc. posted a gross margin of -550.59, reflecting its pricing power and cost economics. The operating margin of -3,083.32 and net profit margin of -3,976.67 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -7.48: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -42.60, meaning MicroVision, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

MicroVision, Inc.'s most recent stock split took place on August 3, 2026 with a 15:1 split ratio.

As of June 30, 2026, MicroVision, Inc. has an Altman Z-Score of -23.56, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.